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Purpose—We evaluated the feasibility of using optical coherence tomography and optical
coherence microscopy technology to assess human kidney morphology.
Materials and Methods—A total of 35 renal specimens from 19 patients, consisting of 12
normal tissues and 23 tumors (16 clear cell renal cell carcinomas, 5 papillary renal cell carcinomas
and 2 oncocytomas) were imaged ex vivo after surgical resection. Optical coherence tomography
and optical coherence microscopy images were compared to corresponding hematoxylin and eosin
histology to identify characteristic features of normal and pathological renal tissues. Three
pathologists blinded to histology evaluated the sensitivity and specificity of optical coherence
microscopy images to differentiate normal from neoplastic renal tissues.
Results—Optical coherence tomography and optical coherence microscopy images of normal
kidney revealed architectural features, including glomeruli, convoluted tubules, collecting tubules
and loops of Henle. Each method of imaging renal tumors clearly demonstrated morphological
changes and decreased imaging depth. Optical coherence tomography and microscopy features
matched well with the corresponding histology. Three observers achieved 88%, 100% and 100%
sensitivity, and 100%, 88% and 100% specificity, respectively, when evaluating normal vs
neoplastic specimens using optical coherence microscopy images with substantial interobserver
agreement (κ = 0.82, p <0.01).
Conclusions—Integrated optical coherence tomography and optical coherence microscopy
imaging provides coregistered, multiscale images of renal pathology in real time without
exogenous contrast medium or histological processing. High sensitivity and specificity were
achieved using optical coherence microscopy to differentiate normal from neoplastic renal tissues,
suggesting possible applications for guiding renal mass biopsy or evaluating surgical margins.
Keywords
kidney; tomography; optical coherence; microscopy; imaging; three-dimensional; kidney
neoplasms
Each year 58,000 new cases of kidney cancer are diagnosed with 13,000 annual deaths due
to the disease.1 RCC, the most common type of adult kidney cancer, accounts for
approximately 85% of renal parenchymal malignancies. Of the RCC phenotypes CC-RCC is
the most common at 70% to 80% of cases while P-RCC is ranked second at 10% to 15%.2
Renal tumors are detected and subsequently staged mainly by CT. Recently using imaging
techniques such as CT, magnetic resonance imaging and ultrasound, the incidence of renal
masses detected in asymptomatic individuals has increased.3
CT or ultrasound-guided RMB provides a preoperative histological diagnosis of renal
masses. Although RMB is highly sensitive for detecting malignancy,4 the false-negative rate
of image guided RMB for SRMs (less than 4 cm) is up to 5%.5 Also, the overall rate of
failed/nondiagnostic RMB remains high at 9% to 37% in a recent clinical review.6
Furthermore, nephron sparing approaches, including PN and focal ablative therapy, recently
showed efficacy comparable to that of radical nephrectomy for localized renal tumors with a
local recurrence rate of less than 3%.7–9 However, positive surgical margins were reported
in up to 7% of patients treated with PN.10,11
Thus, an imaging modality that could be combined with RMB to guide biopsy or assess
surgical margins during PN might decrease biopsy sampling error and the positive margin
rate. To this end several groups have reported kidney imaging using near infrared
reflectance confocal microscopy12 or 2-photon microscopy.13 However, the imaging depth
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of each technique is generally limited to 200 to 300 μm and the imaging field of view is
small.
OCT is an emerging imaging technique that provides 2-dimensional and 3D high resolution,
real-time imaging of tissue morphology in situ.14 OCT operates analogously to ultrasound
but OCT detects back reflected light instead of sound to achieve micron scale resolution.
Using near infrared light the imaging depth of OCT is typically 1 to 2 mm in tissue.
Recently OCT was used to image kidneys in animal models15,16 and human tissues.17,18
However, the transverse resolution of standard OCT systems was not sufficient to identify
features at the cellular level. OCM combines OCT with confocal microscopy to achieve
cellular resolution imaging with improved imaging depth compared to that of standard
confocal microscopy.19
We used an integrated OCT and OCM prototype system developed in our laboratory20 to
image freshly excised normal kidney and renal tumors ex vivo. The system enables
multiscale imaging of specimens at the architectural and cellular levels. OCT and OCM
images from normal, benign and malignant renal tissues were compared to the
corresponding histology to identify characteristic imaging features relevant for diagnosis.
Also, the diagnostic accuracy of OCM imaging for differentiating normal from neoplastic
renal tissues was assessed by observers blinded to histology.
Methods
Integrated OCT and OCM System
A prototype integrated OCT and OCM system was used to image freshly excised renal
tissue. A detailed description of the system was previously published.20,21 Briefly, a
femtosecond Nd:glass laser was spectrally broadened to generate an output spectrum
centered at 1,060 nm with a greater than 200 nm bandwidth. This enabled an axial resolution
of less than 4 μm for OCT and OCM. Transverse resolution was 14 μm for OCT and 2 μm
for OCM. OCT and OCM systems shared the same microscope with a low magnification
objective for OCT and a 40× water immersion IR-Achroplan objective (Carl Zeiss,
Thornwood, New York) for OCM, allowing coregistration of the region of the OCM images
and the 3D OCT data set.
A 3D OCT data set covering a tissue volume of 3.0 × 1.5 × 1.3 mm3 (X × Y × Z) consisted
of 640 cross-sectional OCT images (3,104 × 1,500 pixels, X × Z), which were acquired at 1
frame per second. OCM images covering a field of 400 × 400 μm2 (500 × 700 pixels) were
acquired at 2 frames per second. The 3D OCM data were acquired by translating the sample
stage in depth (Z) at 5 μm per second. After the region of interest was identified on 3D OCT
we sequentially acquired 3D OCM data sets at multiple transverse positions by translating
the specimen horizontally.
Specimen Preparation and Imaging Protocol
The imaging protocol was approved by the institutional review boards at Beth Israel
Deaconess Medical Center and Massachusetts Institute of Technology. Freshly excised renal
specimens were selected based on gross pathological findings. Uninvolved, grossly normal
tissue was also sampled. Specimens (typically 1.0 × 1.0 × 0.5 cm3) were preserved in RPMI
1640 medium (Invitrogen™) and generally imaged within 2 to 6 hours after surgical
resection. A thin cover glass was placed over the specimen surface to create a flat imaging
plane.
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A total of 35 specimens from 19 patients with a median age of 55 years (range 28 to 75)
were imaged, including 12 normal specimens, 16 CC-RCCs, 5 P-RCCs and 2 renal
oncocytomas. An average of 1,317 OCM images (range 483 to 2,414) and 1.65 3D OCT
data sets (range 1 to 3) were acquired per specimen. After imaging the specimen was fixed
in 10% neutral buffered formalin before histological processing. Specimens were sectioned
along the en face planes at different depths and stained with hematoxylin and eosin.
Photomicrographs of hematoxylin and eosin stained histological sections were acquired
using a standard BX40 microscope (Olympus®).
Image Processing and Analysis
En face OCT images (3 × 1.5 mm2, X × Y) were reconstructed from the 3D OCT data sets
by averaging intensity signals over 10 μm depth projections to decrease speckle noise. En
face visualization provides images with uniform brightness across the imaging plane. All
OCT and OCM images were displayed with a reverse gray scale with hyperscattering and
hyposcattering regions shown as black and white, respectively. En face OCT and OCM
images were contrast adjusted and displayed with a square root intensity scale, which has the
advantage that it can display a relatively large dynamic range (when an image has bright and
dark features), preserving fine features while minimizing signal saturation. Cross-sectional
OCT images were displayed with a standard log intensity scale, similar to ultrasound
images.
All OCT and OCM images, and corresponding histological slides were reviewed
retrospectively. Imaging features identified in OCT/OCM images were compared and
matched to the corresponding histopathological slides. Representative OCT/OCM images
and matching histology were selected for presentation.
Blinded Image Classification and Statistical Analysis
A blinded test was performed to evaluate the diagnostic accuracy of OCM imaging in
differentiating normal from neoplastic renal tissues. OCM images were used for the blinded
test, while OCT imaging was used to identify regions of interest for OCM imaging. OCM
images have higher resolution and a large number of OCM images were acquired,
corresponding to different transverse positions and depths. OCM data sets from 35
specimens were divided into a training set of 11, including 4 normal and 7 neoplastic cases,
and a validation set of 24, including 8 normal and 16 neoplastic cases. After reviewing the
training set and the corresponding histology 3 pathologists classified images in the
validation set as normal or neoplastic while blinded to the histological diagnosis. The




Figures 1 to 3 show representative OCT and OCM images of normal human kidney. Figure
1, a demonstrates round, spherical glomeruli and the surrounding convoluted tubules,
consistent with normal renal cortex. The branching vascular network in the glomerulus was
characterized by round, pale regions surrounded by a hyposcattering ring, representing
Bowman's space. Cross-sectional OCT images revealed depth resolved morphological
information. Glomeruli and convoluted tubules were identified (fig. 1, c). Under higher
magnification glomerular structure patterns were seen in more detail (fig. 1, d).
Normal renal medulla is characterized by collecting tubules and loops of Henle (fig. 2). En
face OCT images showed a region rich in round hyposcattering tubules, correlating well
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with histology (fig. 2, a and b). Straight hyposcattering tubular structures were also
observed, elongating toward regions beneath the surface from the cross-sectional OCT
image (fig. 2, c). The OCM image and corresponding histological section revealed that
tubular structures in the medulla were characterized by hyposcattering regions surrounded
by hyperscattering stroma (fig. 2, d and e).
Figure 3 shows OCM images of various functional units in the normal kidney, including the
glomerulus, convoluted tubules, collecting tubules and loops of Henle. Under high
magnification Bowman's capsule space was seen as a crescent separating the glomerular
capillary networks from the adjacent convoluted tubules (fig. 3, a). The convoluted tubules
were characterized by round hyposcattering lumina with a hyperscattering ring boundary,
corresponding to tubule forming epithelial cells (fig. 3, c). In the medulla collecting tubules
and loops of Henle were approximately aligned with each other (fig. 3, e).
Renal Tumors
Figure 4 shows CC-RCC images. Histologically CC-RCC is characterized by sheets and
nests of tumor cells with moderate amounts of clear or granular/eosinophilic cytoplasm.
Increased lipid and glycogen contribute to the clear cytoplasm appearance as well as the
increased refractile contrast between tumor cell cytoplasm and nucleus. Nests of cells are
compartmentalized and surrounded by delicate fibrous septa containing capillaries. The en
face OCT image clearly revealed the tumor interface with adjacent normal tissue (fig. 4, a).
The hyposcattering features likely originated from the refractile contrast of vascular
branching and the cystic architecture observed in the corresponding histology (fig. 4, b).
These features are consistent with characteristics of densely vascular CC-RCC.
Compared to normal kidney the increased scattering in the tumor region resulted in a
marked decrease in imaging depth (mean ± SD 468 ± 138 μm in 24 tumors vs 766 ± 140
μm in 20 normal kidneys, p <0.0001, fig. 4, c). The difference in imaging depth might serve
as an indicator of tumor margin assessment.18 Under high magnification tumor cells were
observed as hyperscattering nests separated by the hyposcattering stroma of a prominent
vascular network (fig. 4, d), consistent with corresponding hematoxylin and eosin stained
histological sections (fig. 4, e).
Figure 5 shows 3 representative OCM images of CC-RCC. Hyperscattering spots were noted
over a less heterogeneous and hyposcattering background (fig. 5, a). On the corresponding
histological section tumor cells were solidly arranged without much intervening vascular
septae (fig. 5, b). Typically, large solid clusters of tumor eventually outgrow the vascular
supply, resulting in necrosis. These large tumor clusters were associated with decreased
refractile contrast compared to that of the compartmentalized tumor nests (figs. 4, b and 5,
c), which were separated from each other by a hyposcattering network of vascular septa.
The tumor interface with the adjacent normal region was also imaged. Histologically there
usually exists a pushing margin or pseudocapsule around the interface between CC-RCC
and adjacent normal kidney. Figure 5, e shows hyperscattering structures aligned in parallel
fashion, representing dense fibrous stroma. In contrast, the tumor region showed
hyperscattering spots over a less heterogeneous hyposcattering background.
Figures 6 and 7 demonstrate OCT and OCM images of P-RCC. Figure 6, a shows the en
face OCT image of the tumor region, where normal kidney structures, such as tubules and
glomeruli, were absent. However, it was difficult to discern a clear papillary growth pattern
from the OCT image since the tumor cells were tightly packed. An incidental finding was
noted on the right portion of the OCT image, where round hyposcattering structures
correlated with inspissated, colloid-like material accumulating inside the renal tubules (fig.
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6, a and b). This feature, reminiscent of thyroid follicles, is termed thyroidization of the
kidney, which implies the possibility of chronic pyelonephritis. These round hyposcattering
structures were also identified over regions beneath the tissue surface (fig. 6, c). Higher
magnification highlighted these features (fig. 6, d).
Figure 7 also shows P-RCC regions. Scattered hyperscattering spots were identified and
characteristic papillary architecture of P-RCC was noted in the photomicrograph (fig. 7).
The overgrowth of tumor cells limited OCT imaging depth (fig. 7, c), which was
significantly shallower than in normal kidneys, as noted. In particular foamy macrophages,
which are often present in papillary RCC,22 were identified as hyperscattering patches on
OCM images (fig. 7, d). This imaging feature may have resulted from the scattering contrast
between surrounding fibrovascular cores and the rich lipid content of macrophages.
Renal oncocytoma is characterized as oxyphilic cells arranged in nests or tubulocysts.23
Round hyperscattering regions, representing the oncocy-toma nested pattern, were identified
on low and high magnification images (fig. 8, a and d). This characteristic growth pattern
was also noted on the cross-sectional OCT image (fig. 8, c). OCT imaging depth in
oncocytoma was similar to that in normal kidneys.
Blinded Image Classification and Statistical Analysis
In the blinded review OCM images were classified based on the mentioned structural
features as normal or neoplastic by the 3 independent pathologists with 88% (95% CI 60–
98), 100% (95% CI 76–100) and 100% sensitivity (95% CI 76–100), and 100% (95% CI
60–100), 88% (95% CI 47–99) and 100% specificity (95% CI 60–100), respectively.
Sensitivity and specificity 95% CIs were large due to the relatively small number of images
and specimens evaluated. The generalized κ value that was calculated suggested substantial
agreement among the 3 pathologists (κ = 0.82, p <0.01).
Discussion
In current clinical practice radiological assessment identifies renal lesions and provides
guidance for RMBs while histopathological examination of biopsies is used to diagnose
renal neoplasms. Our results suggest that OCT/OCM imaging can be used to identify
distinctive morphological patterns of normal and neoplastic human kidney tissues with high
diagnostic accuracy and interobserver agreement. However, due to limited imaging depth
and contrast OCT/OCM techniques are not suited to replace radiological assessment or
histopathological examination of renal tissue. Instead they could serve as an adjunct. OCT/
OCM imaging has advantages in that it can provide pathological information in real time
and be integrated with biopsy and surgical devices.
Many small, benign renal masses are indistinguishable from malignant lesions based on CT
or magnetic resonance imaging. RMB is often done for the preoperative pathological
diagnosis to avoid unnecessary surgery,24 especially in elderly patients or patients with
comorbidities who are not good surgical candidates. Although the diagnostic accuracy of
image-guided RMB has been improved,5,6,25 it is still desirable to improve the accuracy and
yield of RMB sampling techniques to decrease the false-negative rate and the rate of
nondiagnostic/failed biopsies.
A high percent of rebiopsies or surgeries after nondiagnostic biopsy reveal RCC.6 OCT/
OCM can be integrated into biopsy needles. Under CT or ultrasound guidance OCT/OCM
may further guide excisional biopsy by providing real-time images of tissue morphology to
assist biopsy needle placement. This approach promises to decrease the nondiagnostic/failed
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biopsy rate of RMB due to sampling error. To this end more sensitive and cost-effective
RMB might be achieved under OCT/OCM guidance.
Recently PN has become the standard treatment of SRMs, preserving long-term renal
function and leading to decreased occurence of chronic kidney disease.24 The surgical
margin is usually determined by the surgeon based on gross inspection of tumor and
surrounding tissues, although frozen section may also be used to evaluate the margin status
during surgery. Despite recent findings suggesting that positive surgical margins do not
significantly impact long-term recurrence-free survival,24 efforts should be made to achieve
clear surgical margins at initial surgery. The excised specimen near the surgical margin can
be imaged using OCT/OCM, providing real-time assessment of margin status. Imaging
could also be done using a hand held OCT/OCM probe in the open surgical field or by
integrating OCT/OCM with a laparoscope for minimally invasive procedures.
Focal ablative therapies, including cryoablation and radio frequency ablation,9,26 have
evolved as alternate management of SRMs. The metastatic progression rate after focal
ablative therapy is not significantly different from that of PN but the local recurrence rate
after focal ablative therapy, including 4.6% for cryoablation and 11.7% for radio frequency
ablation, is significantly higher.9 OCT/OCM may be integrated with percutaneous ablation
probes or inserted separately into tissues adjacent to the ablation probe to evaluate real-time
changes in tissue morphology in SRMs during focal ablative therapy. This could provide
valuable information to determine the ablative therapy dose. This approach may improve the
efficacy of focal ablative therapy and decrease the high local recurrence rate after such
therapy.
A limitation of our study is the small sample size. As a result, the sensitivity and specificity
95% CI is large and a blinded test to differentiate various renal tumor subtypes was not
possible. However, since OCT/OCM is intended as an adjunct to guide excisional biopsy or
assess the surgical margin rather than diagnose tumor subtypes, it is sufficient to evaluate
sensitivity and specificity for differentiating neoplasms vs normal kidney parenchyma. With
the accrual of more specimens subtype analysis will be done in a later study.
Conclusions
We report OCT and OCM imaging of normal and neoplastic renal specimens. OCT and
OCM provide complementary information on renal morphology in real time based on
intrinsic tissue contrast. Characteristic features of normal renal cortex, medulla and kidney
neoplasms are observed. Changes in morphology and the decrease in imaging depth are
clearly seen in OCT and OCM images of renal tumors. High sensitivity and specificity were
achieved in a blinded test using OCM images to differentiate normal from neoplastic renal
tissues. OCT and OCM imaging technologies promise to become useful tools that will
complement standard radiological and his-tological techniques for assessing renal lesions.
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Abbreviations and Acronyms
3D 3-dimensional
CC-RCC clear cell RCC
CT computerized tomography
OCM optical coherence microscopy
OCT optical coherence tomography
PN partial nephrectomy
P-RCC papillary RCC
RCC renal cell carcinoma
RMB renal mass biopsy
SRM small renal mass
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Normal renal cortex. En face OCT image at depth of about 150 μm (a) and corresponding
histological section (b) demonstrate architectural features of normal cortex, including
glomeruli (G) and convoluted tubules (T). Cross-sectional OCT (CX-OCT) image (c)
corresponds to scanning position marked as white dashed line in (a). OCM image acquired
at depth of about 20 μm (d) and corresponding histological section (e) reveal glomerulus
with surrounding convoluted tubules. Round pale regions represent complex network of
glomerular capillaries (d). Scale bars represent 500 (a to c) and 100 (d to e) μm.
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Normal renal medulla. En face OCT image at depth of about 30 μm beneath tissue surface
(a) and corresponding histological section (b). Cross-sectional OCT (CX-OCT) image,
corresponding to scanning position marked as white dashed line in (a), reveals long straight
tubules (T) elongating beneath tissue surface (c). OCM image about 30 μm beneath tissue
surface (d) and corresponding histological section (e) show architectural features of
medullary structures (T), corresponding to collecting tubules and loops of Henle. Scale bars
represent 500 (a to c) and 100 (d to e) μm.
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OCM (a, c and e) and corresponding histological images (b, d and f) of normal kidney.
Glomerulus (G) about 80 μm beneath tissue surface (a and b). Arrows indicate Bowman's
capsule (a and b). Convoluted tubules (T) (c and d), and collecting tubules and loops of
Henle (arrowhead) of medulla (e and f). Higher magnification revealed these normal kidney
functional units in more detail. Scale bars represent 100 μm.
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CC-RCC. OCT image at depth of about 50 μm (a) of tumor interface with adjacent normal
tissue and corresponding histological section (b). Arrows indicate hyposcattering features
often seen in tumors (a). Cross-sectional OCT (CX-OCT) image at scanning position
marked as white dashed line in (a) reveals differences in imaging depth between normal
tissue (N) and tumor (Tu) (c). OCM image at depth of about 20 μm (d) and corresponding
histological section (e). Arrowhead indicates tumor cells (d and e). Scale bars represent 500
(a to c) and 100 (d and e) μm.
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OCM (a, c and e) and corresponding histological images (b, d and f) of CC-RCC. On OCM
image about 30 μm beneath tissue surface tumor lacked fibrous septations over larger solid
areas (a). Arrows indicate hyperscattering spots. On OCM image (c) about 15 μm beneath
tissue surface over more typical region was noted with tumor cells arranged in nests
(arrowheads) separated by delicate fibrous septae (c and d). Interface between tumor (Tu)
and adjacent fibrous stroma (F) in normal kidney region (e and f). Scale bars represent 100
μm.
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P-RCC. En face OCT image at depth of about 50 μm (a) and corresponding histological
section (b) of interface boundary between P-RCC and surrounding abnormal region. Kidney
thyroidization was noted, shown as round follicle-like structures (arrows) (a and b). F,
fibrous stroma. Cross-sectional OCT (CX-OCT) image at scanning position marked as white
dashed line in (a) (c). OCM image at depth of about 15 μm (d) and corresponding
histological section (e) more clearly reveal hyposcattering structures (arrowhead)
reminiscent of thyroid follicles. Scale bars represent 500 (a to c) and 100 (d to e) μm.
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P-RCC. En face OCT image at depth of about 50 μm (a) and corresponding histological
section (b) in tumor. Cross-sectional OCT (CX-OCT) image at scanning position marked as
white dashed line in (a) shows limited imaging depth due to tumor cell overgrowth (c).
OCM image at depth of about 15 μm (d) and corresponding histological section (e) reveals
tumor containing foamy macrophages (FM). Scale bars represent 500 (a to c) and 100 (d to
e) μm.
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Oncocytoma. En face OCT image at depth of about 60 μm (a) and corresponding
histological section (b) reveals oncocytoma nested growth pattern (arrows). Cross-sectional
OCT (CX-OCT) image at scanning position marked as white dashed line in (a) shows
morphology along depth dimension (c). OCM image at depth of about 30 μm (d) and
corresponding histological section (e) demonstrate oncocytoma nested growth pattern. Scale
bars represent 500 (a to c) and 100 (d to e) μm.
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